VuCOMP, a US-based developer of advanced computer vision systems for the detection of breast cancer, has received US Food and Drug Administration (FDA) approval for its M-Vu computer-aided detection (CAD) for mammography version 3.2.

VuCOMP said the new version of the M-Vu CAD algorithm will offer increased sensitivity, resulting in an improvement in mass detection performance.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The new system is the first mammography CAD product to meet the FDA standard that recommends comprehensive reader studies to prove the effectiveness of CAD systems.

The company continues to offer systematic product updates, fulfilling its commitment to ongoing improvements for its customers.

“The new system is the first mammography CAD product to meet the FDA standard that recommends comprehensive reader studies to prove the effectiveness of CAD systems.”

VuCOMP president Jim Pike said: “We are committed to providing our customers and the industry with the most advanced CAD solution for mammography.

“M-Vu CAD version 3.2 delivers yet another enhancement to our product line, which demonstrates our dedication to the continuous improvement of our offerings.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Apart from M-Vu CAD, the company secured FDA approval for M-Vu Breast Density in December 2013. The two products were adopted by leading radiologists and are in use in clinics worldwide.

In June 2014, VuCOMP secured approval from the FDA for M-Vu CAD for mammography version 3.1. In order to identify areas of a mammogram that are consistent with breast cancer, the M-Vu CAD system uses advanced computer vision algorithms.

M-Vu CAD is approved for digital mammography systems produced by Carestream, Fuji, GE, Giotto, Hologic, Konica Minolta, Philips, Planmed, and Siemens.